Arterial Thromboembolism: Valvular Heart Disease and Prosthetic Heart Valves

  • James E. Dalen


Systemic embolism has long been recognized as a major complication of valvular heart disease, specifically mitral valve disease. In the absence of mitral valve disease or atrial fibrillation (AF), clinically detectable systemic emboli are uncommon in patients with isolated aortic valve disease (1).


Atrial Fibrillation Mitral Regurgitation Valvular Heart Disease Mitral Stenosis Antithrombotic Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Levine HJ, Pauker SG, Salzman EW: Antithrombotic therapy In valvular heart disease. Chest 89, Feb. Supplement, 36S, 1986.Google Scholar
  2. 2.
    Dalen JE: Mitral stenosis. In: Dalen JE, Alpert JS, eds. Valvular Heart Disease, Second Edition, Boston, MA: Little, Brown and Co., 49:1986.Google Scholar
  3. 3.
    Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E: Systemic embolism in mitral valve disease. Br Heart J 32:26, 1970.PubMedCrossRefGoogle Scholar
  4. 4.
    Ellis LB, Harken DE: Arterial embolization in relation to mitral valvuloplasty. Am Heart J 62:611, 1961.PubMedCrossRefGoogle Scholar
  5. 5.
    Bannister RG: The risks of deferring valvotomy in patients with moderate mitral stenosis. Lancet 2:329, 1960.PubMedCrossRefGoogle Scholar
  6. 6.
    Weiss S, Davis D: Rheumatic heart disease. III. Embolic manifestations. Amer Heart J 9:45, 1933.CrossRefGoogle Scholar
  7. 7.
    Graham GK, Taylor JA, Ellis LB, Greenberg DJ, Robbins SL: Studies in mitral stenosis. Arch Int Med 88:632, 1951.CrossRefGoogle Scholar
  8. 8.
    Rowe JC: The course of mitral stenosis without surgery: Ten- and twenty-year perspectives. Ann Intern Med 52:741, 1960.PubMedCrossRefGoogle Scholar
  9. 9.
    Olesen KH: The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 24:349, 1962.PubMedCrossRefGoogle Scholar
  10. 10.
    Sherrid MV, Clark RD, Cohn K: Echocardiographic analysis of left atrial size before and after operation in mitral valve disease. Am J Cardiol 43:171, 1979.PubMedCrossRefGoogle Scholar
  11. 11.
    Wood P: Diseases of the heart and circulation. Philadelphia: JB Lippincott Co, 1956.Google Scholar
  12. 12.
    Barnett HJM: Transient cerebral ischemic: pathogenesis, prognosis and management. Ann R Coll Physicians Surg Can 7:153, 1974.Google Scholar
  13. 13.
    Barnett HJM, Jones ME, Boughner DR, Kostuk WJ: Cerebral ischemic events associated with prolapsing mitral valve. Arch Neurol 33:777, 1976.PubMedCrossRefGoogle Scholar
  14. 14.
    Hirsowitz GS, Saffer D: Hemiplegia and the billowing mitral leaflet syndrome. J Neurol Neurosurg Psychiatry 41:381, 1978.PubMedCrossRefGoogle Scholar
  15. 15.
    Saffro R, Talano JV: Transient ischemic attack associated with mitral systolic clicks. Arch Intern Med 139:693, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Hanson MR, Hodgman JR, Conomy JP: A study of stroke associated with prolapsed mitral valve. Neurology 23:341, 1978.Google Scholar
  17. 17.
    Barnett HJM, Boughner DR, Taylor DW: Further evidence relating mitral valve prolapse to cerebral ischemic events. N Engl J Med 302:139, 1980.PubMedCrossRefGoogle Scholar
  18. 18.
    ACCP-NHLBI National Conference on Antithrombotic Therapy. Dalen JE, Hirsch J, editors. Chest 89, February Supplement, 1986.Google Scholar
  19. 19.
    Pape LA: Pathogenesis and etiology of valvular heart disease. In: Dalen JE, Alpert JS, eds. Valvular Heart Disease, Second Edition, Boston, MA: Little, Brown and Co., 1, 1986.Google Scholar
  20. 20.
    Guthrie JJ, Fairgrieve JJ: Aortic embolism due to a myxoid tumor associated with myocardial calcification. Br Heart J 25:137, 1963.PubMedCrossRefGoogle Scholar
  21. 21.
    Fulkerson PK, Beaver BM, Auseon J, Graber HL: Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. Am J Med 66:967, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Kaiman P, DePace NL, Kotler MN, et al: Mitral annular calcification and echogenic densities in the left ventricuar outflow tract in association with cerebral ischemic events. J Cardiovasc Ultrasonogr 1:155, 1982.Google Scholar
  23. 23.
    Duvoisin GE, Brandenburg RO, McGoon DC: Factors affecting thromboembolism associated with prosthetic heart valves. Circulation Supplement 1:70, 1967.Google Scholar
  24. 24.
    Akbarian M, Austen WG, Yurchak PM, Scanneil JG: Thromboembolic complications of prosthetic cardiac valves. Circulation 37:826, 1968.PubMedCrossRefGoogle Scholar
  25. 25.
    Stein DW, Rahimtoola SH, Kloster FE, Seiden R, Starr A: Thrombotic phenomena with nonanticoagulated, composite-strut aortic prostheses. J Thoracic Cardiovasc Surg 71:680, 1976.Google Scholar
  26. 26.
    Bjork VO, Henze A: Management of thromboembolism after aortic valve replacement with the Bjork-Shiley tilting disc valve. Scand J Thorac Cardiovasc Surg 9:183, 1975.PubMedCrossRefGoogle Scholar
  27. 27.
    Stein PD, Collins JJ Jr, Kantrowitz A: Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 89, February Supplement 46S, 1986.Google Scholar
  28. 28.
    Starr A, Grunkemeier G, Lambert L, Okies JE, Thomas D: Mitral valve replacement. Circulation 54:47 (Suppl III), 1976.Google Scholar
  29. 29.
    Salomon NW, Stinson EB, Griepp RB, Shumway NE: Mitral valve replacement: long-term evaluation of prosthesis-related mortality and morbidity. Circulation 56:94, 1977.Google Scholar
  30. 30.
    Edmunds LH: Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 34:96, 1982.PubMedCrossRefGoogle Scholar
  31. 31.
    Ionescu MI, Smith DR, Hasan SS, Chidambaram M, Tandon AP: Clinical durability of the pericardial xenograft valve: Ten years experience with mitral replacement. Ann Thorac Surg 34:265, 1982.PubMedCrossRefGoogle Scholar
  32. 32.
    Oyer PE, Stinson EB, Griepp RB, Shumway NE: Valve replacement with the Starr-Edwards and Hancock prostheses: comparative analysis of late morbidity and mortality. Ann Surg 186:301, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Nunez L, Gil Aguado M, Larrea JL: Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. Ann Thorac Surg 37:84, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • James E. Dalen
    • 1
  1. 1.University of Massachusetts at WorcesterWorcesterUSA

Personalised recommendations